To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsors
![Rep. Auchincloss, Jake [D-MA-4]](https://bioguide.congress.gov/bioguide/photo/A/A000148.jpg)
Actions
2026-10-22T00:00:00
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2026-10-22T00:00:00
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2026-10-22T00:00:00
Introduced in House
2026-10-22T00:00:00
Introduced in House
Policy Areas
Track this bill on CivicBeacon
Get push notifications when this bill is updated, contact your reps, and take action.
